Cargando…
SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
Autor principal: | Elkoshi, Zeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927656/ https://www.ncbi.nlm.nih.gov/pubmed/35309339 http://dx.doi.org/10.3389/fimmu.2022.856072 |
Ejemplares similares
-
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022) -
SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
por: Rahmani, Shayan, et al.
Publicado: (2022) -
Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater
por: Ahmed, Warish, et al.
Publicado: (2022) -
First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
por: Carrazco-Montalvo, A., et al.
Publicado: (2022) -
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action
por: Choudhary, Om Prakash, et al.
Publicado: (2022)